Neurotech International Ltd
ASX:NTI
Neurotech International Ltd
ASX:NTI
Price:
0.071 AUD
-1.39%
Market Closed
Updated:
Jun 1, 2024
Neurotech International Ltd
Cost of Revenue
|
Neurotech International Ltd
Cost of Revenue Peer Comparison
Comparables:
IPD
C
CYC
COH
OIL
EMV
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Neurotech International Ltd
ASX:NTI
|
Cost of Revenue
AU$870
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Cost of Revenue
-AU$1.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cost of Revenue
-AU$10.3m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-11%
|
|
|
Cochlear Ltd
ASX:COH
|
Cost of Revenue
-AU$527.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cost of Revenue
AU$815.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Neurotech International Ltd's Cost of Revenue?
Cost of Revenue
870
AUD
870
AUD
Based on the financial report for Dec 31, 2023, Neurotech International Ltd's Cost of Revenue amounts to 870 AUD.
What is Neurotech International Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
-82%
-82%
Over the last year, the Cost of Revenue growth was -82%.
You don't have any saved screeners yet
